119 related articles for article (PubMed ID: 31561045)
21. Synthesis and biological evaluation of novel 5-alkyl-2-arylthio-6-((3,4-dihydroquinolin-1(2H)-yl)methyl)pyrimidin-4(3H)-ones as potent non-nucleoside HIV-1 reverse transcriptase inhibitors.
Zhang J; Zhan P; Wu J; Li Z; Jiang Y; Ge W; Pannecouque C; De Clercq E; Liu X
Bioorg Med Chem; 2011 Jul; 19(14):4366-76. PubMed ID: 21683601
[TBL] [Abstract][Full Text] [Related]
22. Design, synthesis and anti-HIV-1 RT evaluation of 2-(benzyl(4-chlorophenyl)amino)-1-(piperazin-1-yl)ethanone derivatives.
Chander S; Wang P; Ashok P; Yang LM; Zheng YT; Sankaranarayanan M
Bioorg Med Chem Lett; 2017 Jan; 27(1):61-65. PubMed ID: 27894873
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and anti-HIV activity of novel 3-substituted phenyl-6,7-dimethoxy-3a,4-dihydro-3H-indeno[1,2-c]isoxazole analogues.
Ali MA; Ismail R; Choon TS; Yoon YK; Wei AC; Pandian S; Samy JG; De Clercq E; Pannecouque C
Acta Pol Pharm; 2011; 68(3):343-8. PubMed ID: 21648188
[TBL] [Abstract][Full Text] [Related]
24. Arylazolyl(azinyl)thioacetanilides. Part 10: design, synthesis and biological evaluation of novel substituted imidazopyridinylthioacetanilides as potent HIV-1 inhibitors.
Li X; Zhan P; Liu H; Li D; Wang L; Chen X; Liu H; Pannecouque C; Balzarini J; De Clercq E; Liu X
Bioorg Med Chem; 2012 Sep; 20(18):5527-36. PubMed ID: 22883027
[TBL] [Abstract][Full Text] [Related]
25. New anti-HIV derivatives: synthesis and antiviral evaluation.
De Michelis C; Rocheblave L; Priem G; Chermann JC; Kraus JL
Bioorg Med Chem; 2000 Jun; 8(6):1253-62. PubMed ID: 10896105
[TBL] [Abstract][Full Text] [Related]
26. Rational design, synthesis, anti-HIV-1 RT and antimicrobial activity of novel 3-(6-methoxy-3,4-dihydroquinolin-1(2H)-yl)-1-(piperazin-1-yl)propan-1-one derivatives.
Chander S; Wang P; Ashok P; Yang LM; Zheng YT; Murugesan S
Bioorg Chem; 2016 Aug; 67():75-83. PubMed ID: 27288643
[TBL] [Abstract][Full Text] [Related]
27. Synthesis of 5-alkynylated d4T analogues as potential HIV-1 reverse transcriptase inhibitors.
Ciurea A; Fossey C; Gavriliu D; Delbederi Z; Sugeac E; Laduree D; Schmidt S; Laumond G; Aubertin AM
J Enzyme Inhib Med Chem; 2004 Dec; 19(6):511-9. PubMed ID: 15662955
[TBL] [Abstract][Full Text] [Related]
28. Geometrically and conformationally restrained cinnamoyl compounds as inhibitors of HIV-1 integrase: synthesis, biological evaluation, and molecular modeling.
Artico M; Di Santo R; Costi R; Novellino E; Greco G; Massa S; Tramontano E; Marongiu ME; De Montis A; La Colla P
J Med Chem; 1998 Oct; 41(21):3948-60. PubMed ID: 9767632
[TBL] [Abstract][Full Text] [Related]
29. Could the FDA-approved anti-HIV PR inhibitors be promising anticancer agents? An answer from enhanced docking approach and molecular dynamics analyses.
Arodola OA; Soliman ME
Drug Des Devel Ther; 2015; 9():6055-65. PubMed ID: 26622167
[TBL] [Abstract][Full Text] [Related]
30. Discovery of piperidine-linked pyridine analogues as potent non-nucleoside HIV-1 reverse transcriptase inhibitors.
Chen X; Li Y; Ding S; Balzarini J; Pannecouque C; De Clercq E; Liu H; Liu X
ChemMedChem; 2013 Jul; 8(7):1117-26. PubMed ID: 23650275
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and substrate properties towards HIV-1 reverse transcriptase of new diphosphate analogues of 9-[(2-phosphonomethoxy)ethyl]adenine.
Laux WH; Priet S; Alvarez K; Peyrottes S; Périgaud C
Antivir Chem Chemother; 2018; 26():2040206618757636. PubMed ID: 29436843
[TBL] [Abstract][Full Text] [Related]
32. A new potential approach to block HIV-1 replication via protein-protein interaction and strand-transfer inhibition.
Ferro S; De Luca L; Lo Surdo G; Morreale F; Christ F; Debyser Z; Gitto R; Chimirri A
Bioorg Med Chem; 2014 Apr; 22(7):2269-79. PubMed ID: 24618511
[TBL] [Abstract][Full Text] [Related]
33. Discovery of biphenyl-substituted diarylpyrimidines as non-nucleoside reverse transcriptase inhibitors with high potency against wild-type and mutant HIV-1.
Jin K; Yin H; De Clercq E; Pannecouque C; Meng G; Chen F
Eur J Med Chem; 2018 Feb; 145():726-734. PubMed ID: 29353724
[TBL] [Abstract][Full Text] [Related]
34. Synthesis, Biological Evaluation, and Molecular Docking Studies of Novel 4-[4-Arylpyridin-1(4H)-yl]benzoic Acid Derivatives as Anti-HIV-1 Agents.
Sepehri S; Soleymani S; Zabihollahi R; Aghasadeghi MR; Sadat M; Saghaie L; Fassihi A
Chem Biodivers; 2017 Dec; 14(12):. PubMed ID: 28834275
[TBL] [Abstract][Full Text] [Related]
35. Synthesis of prodrug-type anti-HIV agents conjugating a REVERSE transcriptase inhibitor to a HIV-1 integrase inhibitor by a spontaneously cleavable linker.
Fossey C; Vu AH; Vidu A; Zarafu I; Laduree D; Schmidt S; Laumond G; Aubertin AM
J Enzyme Inhib Med Chem; 2007 Oct; 22(5):591-607. PubMed ID: 18035828
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and evaluation of N-aryl pyrrolidinones as novel anti-HIV-1 agents. Part 1.
Wu B; Kuhen K; Ngoc Nguyen T; Ellis D; Anaclerio B; He X; Yang K; Karanewsky D; Yin H; Wolff K; Bieza K; Caldwell J; He Y
Bioorg Med Chem Lett; 2006 Jul; 16(13):3430-3. PubMed ID: 16632349
[TBL] [Abstract][Full Text] [Related]
37. A Parallel Synthesis Approach to the Identification of Novel Diheteroarylamide-Based Compounds Blocking HIV Replication: Potential Inhibitors of HIV-1 Pre-mRNA Alternative Splicing.
Cheung PK; Horhant D; Bandy LE; Zamiri M; Rabea SM; Karagiosov SK; Matloobi M; McArthur S; Harrigan PR; Chabot B; Grierson DS
J Med Chem; 2016 Mar; 59(5):1869-79. PubMed ID: 26878150
[TBL] [Abstract][Full Text] [Related]
38. 2-(2,6-Dihalophenyl)-3-(pyrimidin-2-yl)-1,3-thiazolidin-4-ones as non-nucleoside HIV-1 reverse transcriptase inhibitors.
Rao A; Balzarini J; Carbone A; Chimirri A; De Clercq E; Monforte AM; Monforte P; Pannecouque C; Zappalà M
Antiviral Res; 2004 Aug; 63(2):79-84. PubMed ID: 15302136
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and in vitro anti-HIV activity of N-1,3-benzo[d]thiazol-2-yl-2-(2-oxo-2H-chromen-4-yl)acetamide derivatives using MTT method.
Bhavsar D; Trivedi J; Parekh S; Savant M; Thakrar S; Bavishi A; Radadiya A; Vala H; Lunagariya J; Parmar M; Paresh L; Loddo R; Shah A
Bioorg Med Chem Lett; 2011 Jun; 21(11):3443-6. PubMed ID: 21515046
[TBL] [Abstract][Full Text] [Related]
40. New HIV-1 replication inhibitors of the styryquinoline class bearing aroyl/acyl groups at the C-7 position: synthesis and biological activity.
Normand-Bayle M; Bénard C; Zouhiri F; Mouscadet JF; Leh H; Thomas CM; Mbemba G; Desmaële D; d'Angelo J
Bioorg Med Chem Lett; 2005 Sep; 15(18):4019-22. PubMed ID: 16002283
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
